Close Menu

NEW YORK ─ The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) on Monday announced that it has awarded almost $12.9 million to Ortho Clinical Diagnostics to develop a high-throughput, automated COVID-19 antigen test and to further develop two of its SARS-CoV-2 antibody tests currently authorized for emergency use.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.